Fidaxomicin
3 NDCs across 3 manufacturers|2 Generic,1 Brand
Fidaxomicin is used to treat pseudomembranous enterocolitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 27, 2011, and the first generic was approved Jan 16, 2024. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $154 million on Fidaxomicin across 35,000 claims for 26,000 beneficiaries.
Fidaxomicin is available as 3 NDCs from 3 manufacturers (2 generic, 1 brand), with NADAC prices from $95.02 to $248.47 per EA — the most expensive product costs about 2.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
2G / 1B
Manufacturers
3
competing in market
Price Spread
$95.02 – $248.47
per EA
7d Activity
avg -2.3% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
3 manufacturers producing FIDAXOMICIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DIFICID 200 MG TABLET | $248.4654 per EA | -0.05% |
FIDAXOMICIN 200 MG TABLET | $95.0247 per EA | -3.36% |
FIDAXOMICIN 200 MG TABLET | $95.0247 per EA | -3.36% |
Frequently Asked Questions
What is Fidaxomicin used to treat?
Fidaxomicin is used to treat pseudomembranous enterocolitis, per the National Library of Medicine's MED-RT classification.
When did Fidaxomicin become available as a generic?
FDA approved the first generic Fidaxomicin (ANDA) on Jan 16, 2024. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Fidaxomicin?
In 2024, Medicare Part D spent $154 million on Fidaxomicin across 35,000 claims for 26,000 beneficiaries.
How many Fidaxomicin products are on the market?
The Fidaxomicin drug market contains 3 NDCs from 3 manufacturers — 2 generic and 1 brand product.
What is the price range for Fidaxomicin?
NADAC reference prices for Fidaxomicin range from $95.0247 to $248.4654 per EA — the most expensive product costs about 2.6× the cheapest.
Is generic Fidaxomicin cheaper than brand?
The average generic NADAC for Fidaxomicin is $95.0247 per EA, versus $248.4654 for brand-labeled products — brand versions average about 2.6× the generic price.
Which manufacturers make Fidaxomicin?
3 manufacturers list Fidaxomicin in NADAC. Ranked by number of NDCs, the largest are Merck Sharp & Dohme LLC (1), Teva Pharmaceuticals USA Inc. (1), Apotex Corp. (1).
How has the price of Fidaxomicin changed recently?
Over the past 7 days, 0 Fidaxomicin NDCs rose and 3 fell, with a market-wide average change of -2.3%.